Skip to main content

Table 2 Participant characteristics at baseline

From: Quality of life impact and recovery after ureteroscopy and stent insertion: insights from daily surveys in STENTS

Characteristic Participants (n = 40)
Sex: female 21 (53%)
Race  
 White 38 (95%)
 Black 2 (5%)
Ethnicity: Hispanic/Latinx 3 (8%)
Age (years)  
 Median (IQR) 43.5 (28.5, 57.5)
 Mean (SD) 43.1 (17.6)
Medical history  
 Depression 9 (23%)
 Anxiety 8 (20%)
 Mood disorder (other) 1 (3%)
 Chronic pain condition 7 (18%)
Previous stone history 23 (58%)
 Prior ureteroscopy 12 (30%)
 Prior ureteral stent placement 13 (33%)
 Severe pain with prior ureteral stent 8 (20%)
 Severe urinary symptoms with prior ureteral stent 6 (15%)
Medication use in past 30 days  
 Opioids 11 (28%)
 NSAIDs 20 (50%)
 Tamsulosin (or alpha blocker) 16 (40%)
 Oxybutynin (or anticholinergic) 3 (8%)
  1. Data shown are n (%) except where indicated. IQR = 25th, 75th percentiles; SD = standard deviation; NSAIDs = nonsteroidal anti-inflammatory drugs